BiotechTube
Home/Bio-Path Holdings/Vikram Grover
VG

Vikram Grover

Chief Executive Officer & Chairman of the Board

Bio-Path Holdings

Therapeutic Areas

OncologyHematologic CancerSolid Tumors

Bio-Path Holdings Pipeline

DrugIndicationPhase
Prexigebersen (BP1001)Acute Myeloid Leukemia (AML)Phase 2
BP1001-AAdvanced Solid TumorsPhase 1
BP1002Refractory/Relapsed LymphomaPhase 1
BP1003Not SpecifiedPreclinical